Claims for Patent: 7,202,356
✉ Email this page to a colleague
Summary for Patent: 7,202,356
Title: | Fructose-bisphosphate aldolase regulatory sequences for gene expression in oleaginous yeast |
Abstract: | The regulatory sequences (i.e., promoter regions, introns and enhancers) associated with the Yarrowia lipolytica gene encoding fructose bis-phospate aldolase (FBA1) have been found to be particularly effective for the expression of heterologus genes in oleaginous yeast. The promoter regions of the invention have been shown to drive high-level expression of genes involved in the production of .omega.-3 and .omega.-6 fatty acids. |
Inventor(s): | Pollak; Dana M. Walters (Media, PA), Zhu; Quinn Qun (West Chester, PA) |
Assignee: | E. I. du Pont de Nemours and Company (Wilmington, DE) |
Application Number: | 10/987,548 |
Patent Claims: | 1. A method for the expression of a coding region of interest in a transformed yeast cell comprising: (a) providing a transformed yeast cell having a chimeric gene
comprising: (i) a regulatory sequence of the Yarrowia fba1 gene; and, (ii) a coding region of interest expressible in the yeast cell; wherein the regulatory sequence is operably linked to the coding region of interest; and (b) growing the transformed
yeast cell of step (a) under conditions whereby the chimeric gene of step (a) is expressed.
2. A method according to claim 1 wherein the regulatory sequence of the Yarrowia fba1 gene is selected from the group consisting of: a FBA promoter region; a FBAIN promoter region; a FBAINm promoter region; and a chimeric promoter comprising the fba1 intron. 3. A method according to claim 1 wherein the regulatory sequence of the Yarrowia fba1 gene is isolated from Yarrowia lipolytica. 4. A method according to claim 1 wherein the transformed yeast cell is an oleaginous yeast. 5. A method of claim 4, wherein the oleaginous yeast is a member of a genus selected from the group consisting of Yarrowia, Candida, Rhodotorula, Rhodosporidium, Cryptococcus, Trichosporon and Lipomyces. 6. A method according to claim 1 wherein the coding region of interest encodes a polypeptide selected from the group consisting of: desaturases, elongases, acyltransferases, aminopeptidases, amylases, carbohydrases, carboxypeptidases, catalyases, cellulases, chitinases, cutinases, cyclodextrin glycosyltransferases, deoxyribonucleases, esterases, .alpha.-galactosidases, .beta.-galactosidases, glucoamylases, .alpha.-glucosidases, .beta.-glucanases, .beta.-glucosidases, invertases, laccases, lipases, mannosidases, mutanases, oxidases, pectinolytic enzymes, peroxidases, phospholipases, phytases, polyphenoloxidases, proteolytic enzymes, ribonucleases, trausglutaminases and xylanases. 7. A plasmid comprising a regulatory sequence of a Yarrowia fab1 gene selected from the group consisting of a FBA promoter region, FBAIN promoter region and an FBAINm promoter region. 8. A plasmid comprising fba1 intron of a Yarrowia fab1 gene. |
Details for Patent 7,202,356
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2023-11-14 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2023-11-14 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2023-11-14 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.